Close Menu

NEW YORK — Pharmacogenetic test results might not lead patients to avoid certain helpful treatments as feared, a new clinical trial focusing on statins has found.

Pharmacogenetic testing enables patients to learn whether they harbor any genetic variants that could affect their response to particular drugs, with an eye toward selecting more effective therapies. But there are also concerns that positive test results could lead patients to avoid drugs for their possible adverse effects and shy away from treatments from which they may still benefit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.

Apr
21
Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.